News Agency
Men's Weekly

ATH434 protects brain cells and improves motor function in Parkinsonian disorder

  • Written by PR Newswire

Oral presentation at the American Academy of Neurology

ATH434 protects brain cells and improves motor function in Parkinsonian disorder

MELBOURNE, Australia , April 21, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced an oral presentation of expanded animal data to support the commercialisation of its lead compound ATH434 in clinical development for the...

Read more: ATH434 protects brain cells and improves motor function in Parkinsonian disorder

Insurance Industry Innovation Through VR Training

Australia's insurance industry, managing over $120 billion in annual premiums, operates at the intersection of financial services and human crisis. Insurance professionals must navigate emotionally charged situations daily, from claim denials to disaster responses. Leading insurers are now implementing best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion